Personalization of mathematical models of human atrial action potential
暂无分享,去创建一个
Andrey V. Pikunov | Roman A. Syunyaev | Vanessa Steckmeister | Ingo Kutschka | Niels Voigt | Igor R. Efimov | I. Efimov | N. Voigt | R. Syunyaev | I. Kutschka | Vanessa Steckmeister
[1] Gernot Plank,et al. A work flow to build and validate patient specific left atrium electrophysiology models from catheter measurements , 2018, Medical Image Anal..
[2] K. Aras,et al. Genetic algorithm-based personalized models of human cardiac action potential , 2019, bioRxiv.
[3] J. Nerbonne,et al. Atrial L-type Ca2+ currents and human atrial fibrillation. , 1999, Circulation research.
[4] Igor R. Efimov,et al. Critical Volume of Human Myocardium Necessary to Maintain Ventricular Fibrillation , 2018, Circulation. Arrhythmia and electrophysiology.
[5] B. Fermini,et al. Differences in rate dependence of transient outward current in rabbit and human atrium. , 1992, The American journal of physiology.
[6] S. Nattel,et al. Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy , 2020, Circulation research.
[7] J. Magyar,et al. Effects of endothelin-1 on calcium and potassium currents in undiseased human ventricular myocytes , 2000, Pflügers Archiv.
[8] Stanley Nattel,et al. Regional and tissue specific transcript signatures of ion channel genes in the non‐diseased human heart , 2007, The Journal of physiology.
[9] Yoram Rudy,et al. Simulation of the Undiseased Human Cardiac Ventricular Action Potential: Model Formulation and Experimental Validation , 2011, PLoS Comput. Biol..
[10] Joseph L Greenstein,et al. Mathematical simulations of ligand-gated and cell-type specific effects on the action potential of human atrium. , 2008, Progress in biophysics and molecular biology.
[11] D. Dobrev,et al. Role of IKur in Controlling Action Potential Shape and Contractility in the Human Atrium: Influence of Chronic Atrial Fibrillation , 2004, Circulation.
[12] Mathias Wilhelms,et al. Benchmarking electrophysiological models of human atrial myocytes , 2013, Front. Physio..
[13] M. Chung,et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[14] S Nattel,et al. Properties of human atrial ICa at physiological temperatures and relevance to action potential. , 1997, The American journal of physiology.
[15] F. Mason,et al. Altered atrial cytosolic calcium handling contributes to the development of postoperative atrial fibrillation , 2020, Cardiovascular research.
[16] Na Li,et al. Cellular and Molecular Mechanisms of Atrial Arrhythmogenesis in Patients With Paroxysmal Atrial Fibrillation , 2014, Circulation.
[17] D. Levy,et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.
[18] J. Jalife,et al. Human Atrial Action Potential and Ca2+ Model: Sinus Rhythm and Chronic Atrial Fibrillation , 2011, Circulation research.
[19] Carlos Sánchez,et al. Inter-Subject Variability in Human Atrial Action Potential in Sinus Rhythm versus Chronic Atrial Fibrillation , 2014, PloS one.
[20] T. Wieland,et al. Enhanced Sarcoplasmic Reticulum Ca2+ Leak and Increased Na+-Ca2+ Exchanger Function Underlie Delayed Afterdepolarizations in Patients With Chronic Atrial Fibrillation , 2012, Circulation.
[21] M. Borggrefe,et al. Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation , 2015, Circulation.
[22] R F Bosch,et al. Ionic mechanisms of electrical remodeling in human atrial fibrillation. , 1999, Cardiovascular research.
[23] M. Borggrefe,et al. Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy , 2017, European heart journal.
[24] Stefano Severi,et al. Development, calibration, and validation of a novel human ventricular myocyte model in health, disease, and drug block , 2019, eLife.
[25] Nolwenn Le Meur,et al. Human Atrial Ion Channel and Transporter Subunit Gene-Expression Remodeling Associated With Valvular Heart Disease and Atrial Fibrillation , 2005, Circulation.
[26] Godfrey L. Smith,et al. Dynamic clamping human and rabbit atrial calcium current: narrowing I CaL window abolishes early afterdepolarizations , 2019, The Journal of physiology.
[27] Stefan L. Zimmerman,et al. Computationally guided personalized targeted ablation of persistent atrial fibrillation , 2019, Nature Biomedical Engineering.